Sex Toys Blog, Sexual Health

005 Improvement in Sexual Function Associated with Prostatic Artery Embolization (PAE): An Emerging Treatment Option for Men with Symptomatic BPH

There is a critical need for a minimally invasive treatment for symptomatic BPH, that does not adversely impact sexual function. Prostate artery embolization (PAE) is a new, FDA-approved treatment that significantly reduces symptom burden in patients with BPH, particularly in patients with larger prostate glands. We evaluated the impact of PAE on erectile and ejaculatory function in patients undergoing PAE at our center.

Read more

Sex Toys Blog, Sexual Health

004 Convective Radiofrequency Thermal Therapy (Rezum®) Effectively Treats Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia Regardless of Obesity while Preserving Erectile and Ejaculatory Function

Obesity is a component of metabolic syndrome, which influences erectile dysfunction, lower urinary tract symptoms (LUTS), and response to benign prostatic hyperplasia (BPH) treatment. We assessed the effect of obesity on voiding and sexual function parameters in men treated with convective radiofrequency thermal therapy, Rezum (REZ), for LUTS/BPH and compared results between obese (BMI > 30) and non-obese subjects.

Read more

Sex Toys Blog, Sexual Health

003 Effects of Udenafil 75mg (ZydenaŽ) Administration on Post-Micturition Dribbling (PMD) in Men: A Prospective, Multi-Centered, Double-Blinded, Placebo-Controlled, and Randomized Clinical Study

Post-Micturition Dribbling (PMD) is a painful symptom for middle aged men. It is estimated that decreased volume of penile corpus cavernosa and dilation of bulbous urethra are related to PMD with the aging process. However, the exact etiology of PMD is not yet determined. We have studied the effectiveness of Udenafil 75mg daily medication in treating PMD patients.

Read more

Sex Toys Blog, Sexual Health

002 Simulated Over-the-counter use of Tamsulosin by Men with Urinary Symptoms

Lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) are common in men, however, many remain undertreated. Hence, self-management with over-the-counter (OTC) drugs is helpful. The FDA requires a rigorous approval process for prescription (Rx)-to-OTC switches. Currently, tamsulosin is being evaluated for OTC use in men with bothersome urinary symptoms. In a simulated OTC setting, we assessed the ability of men interested in a self-management option to appropriately follow instructions in a proposed Drug Facts Label (label).

Read more

Sex Toys Blog, Sexual Health

001 Urinary and Sexual Function in 411 Obese Hypogonadal Men with and without Testosterone Therapy: Real-life Evidence from a 10-registry Study in a Urological Office

Obesity negatively affects urinary and erectile function. We investigated effects of long-term testosterone therapy (TTh) from a registry including an untreated hypogonadal control group.

Read more

Sex Toys Blog, Sexual Health

015 Efficacy of Flibanserin by Duration of Hypoactive Sexual Desire Disorder in Premenopausal Women

Flibanserin, a 5-HT1A agonist and 5-HT2A antagonist, is indicated for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. This post hoc analysis evaluated the efficacy of flibanserin treatment by duration of HSDD.

Read more

Sex Toys Blog, Sexual Health

013 Description of a Patient Reported Outcome approved by FDA for use in Phase III studies in Premature Ejaculation

This presentation will contain a description of a new patient reported outcome (PRO) approved for use in phase III studies by FDA. The Premature Ejaculation Bothersome Evaluation Questionnaire (PEBEQTM) is a proprietary tool that can be used by physicians, in clinical trials and potentially in diagnosis, to address the multi-dimensional concept of “bothersomeness” experienced by men with PE.

Read more